$225 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 81 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 9.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
OCLR | Buy | Oclaro, Inc. | $24,336,000 | +21.7% | 10,768,344 | +6.7% | 10.84% | +22.5% |
EMKR | Buy | Emcore Corp. | $19,229,000 | +15.5% | 3,194,223 | +4.4% | 8.56% | +16.2% |
FNSR | Buy | Finisar Corp. | $17,541,000 | -15.9% | 981,569 | +0.5% | 7.81% | -15.3% |
SUPN | Buy | Supernus Pharmaceuticals, Inc. | $15,124,000 | +103.9% | 890,705 | +45.2% | 6.74% | +105.2% |
XENT | Buy | Intersect ENT Inc. | $11,961,000 | +461.8% | 417,788 | +406.8% | 5.33% | +465.5% |
IG | Buy | IGI Laboratories, Inc. | $11,734,000 | -5.4% | 1,862,475 | +22.5% | 5.23% | -4.8% |
NEO | Buy | NeoGenomics Inc | $10,626,000 | +30.7% | 1,964,198 | +12.8% | 4.73% | +31.5% |
RTIX | Buy | RTI Surgical Inc. | $10,060,000 | +42.3% | 1,557,262 | +8.8% | 4.48% | +43.2% |
GIMO | Buy | Gigamon Inc. | $9,815,000 | +512.3% | 297,530 | +294.2% | 4.37% | +516.5% |
IL | Buy | IntraLinks Holdings Inc. | $7,180,000 | +356.7% | 602,840 | +296.6% | 3.20% | +359.5% |
ATRC | Buy | AtriCure Inc. | $5,017,000 | +21.1% | 203,620 | +0.7% | 2.23% | +21.9% |
AKRXQ | Buy | Akorn, Inc. | $4,067,000 | -7.8% | 93,153 | +0.3% | 1.81% | -7.3% |
CTCT | Buy | Constant Contact, Inc. | $3,263,000 | +52.1% | 113,473 | +102.0% | 1.45% | +52.9% |
GPRO | New | GoPro Inc.cl a | $3,240,000 | – | 61,460 | +100.0% | 1.44% | – |
CEMP | Buy | Cempra, Inc | $3,103,000 | +647.7% | 90,312 | +647.3% | 1.38% | +651.1% |
LGND | Buy | Ligand Pharmaceuticals Inc | $2,809,000 | +48.7% | 27,844 | +13.6% | 1.25% | +49.6% |
ARRY | Buy | Array Biopharma Inc. | $2,762,000 | -1.7% | 383,022 | +0.5% | 1.23% | -1.0% |
SCON | Buy | Superconductor Technologies, Inc. | $2,695,000 | -16.6% | 2,566,277 | +12.0% | 1.20% | -16.1% |
ENZ | Buy | Enzo Biochem, Inc | $2,492,000 | +29.7% | 822,522 | +26.3% | 1.11% | +30.4% |
ANGO | Buy | Angiodynamics, Inc. | $2,328,000 | -7.5% | 141,923 | +0.3% | 1.04% | -6.9% |
FLDM | Buy | Fluidigm Corp. | $1,943,000 | -11.5% | 80,288 | +54.0% | 0.86% | -10.9% |
NXTM | Buy | NxStage Medical, Inc | $1,669,000 | +390.9% | 116,850 | +494.7% | 0.74% | +395.3% |
WFC | Buy | Wells Fargo & Co. | $1,147,000 | +4.1% | 20,399 | +0.7% | 0.51% | +4.7% |
EMN | Buy | Eastman Chemical Co. | $1,022,000 | +40.2% | 12,496 | +18.7% | 0.46% | +40.9% |
HRL | Buy | Hormel Foods Corporation | $1,006,000 | +0.9% | 17,855 | +1.8% | 0.45% | +1.6% |
JWN | Buy | Nordstrom Inc. | $964,000 | -1.5% | 12,940 | +6.2% | 0.43% | -0.9% |
AFL | Buy | Aflac Incorporated | $912,000 | +2.6% | 14,659 | +5.5% | 0.41% | +3.3% |
AXP | Buy | American Express Company | $899,000 | +4.4% | 11,571 | +5.0% | 0.40% | +5.0% |
TROW | Buy | T. Rowe Price | $881,000 | -3.2% | 11,330 | +0.8% | 0.39% | -2.7% |
MXL | Buy | MaxLinear, Inc.cl a | $871,000 | +51.5% | 71,949 | +1.7% | 0.39% | +52.8% |
JNJ | Buy | Johnson & Johnson | $869,000 | -2.2% | 8,913 | +0.8% | 0.39% | -1.5% |
PG | Buy | The Procter & Gamble Company | $869,000 | -3.8% | 11,112 | +0.8% | 0.39% | -3.2% |
VZ | Buy | Verizon Communications, Inc. | $848,000 | -3.9% | 18,191 | +0.3% | 0.38% | -3.1% |
NOV | Buy | National Oilwell Varco Inc. | $734,000 | +13.4% | 15,205 | +17.5% | 0.33% | +14.3% |
XOM | Buy | Exxon Mobil Corporation | $705,000 | -1.0% | 8,470 | +1.1% | 0.31% | -0.3% |
CVLT | Buy | CommVault Systems Inc. | $584,000 | -2.8% | 13,761 | +0.1% | 0.26% | -2.3% |
FLML | Buy | Flamel Technologies SA Spons Asponsored adr | $496,000 | +56.5% | 23,419 | +32.8% | 0.22% | +57.9% |
VCYT | Buy | Veracyte Inc. | $435,000 | +62.3% | 39,085 | +6.2% | 0.19% | +63.0% |
SIEN | New | Sientra, Inc. | $268,000 | – | 10,615 | +100.0% | 0.12% | – |
AERI | Buy | Aerie Pharmaceuticals, Inc. | $240,000 | -7.3% | 13,590 | +64.5% | 0.11% | -7.0% |
AAPL | Buy | Apple Inc. | $236,000 | +12.9% | 1,880 | +11.9% | 0.10% | +14.1% |
CLDX | Buy | Celldex Therapeutics Inc. | $219,000 | -5.2% | 8,692 | +4.9% | 0.10% | -3.9% |
BLUE | New | Bluebird Bio. Inc | $212,000 | – | 1,261 | +100.0% | 0.09% | – |
HWAY | New | Healthways Inc. | $180,000 | – | 15,040 | +100.0% | 0.08% | – |
NVDQ | Buy | Novadaq Technologies Inc. | $150,000 | -21.5% | 12,417 | +5.8% | 0.07% | -21.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NeoGenomics Inc. | 26 | Q3 2019 | 8.2% |
RTI Surgical Inc. | 26 | Q3 2019 | 6.0% |
Omnicell Inc. | 26 | Q3 2019 | 4.7% |
AtriCure Inc. | 26 | Q3 2019 | 4.6% |
Ligand Pharmaceuticals Inc. | 26 | Q3 2019 | 4.5% |
SPDR Trust Ser 1 | 26 | Q3 2019 | 2.3% |
Marriott Intl. Inc. | 26 | Q3 2019 | 1.5% |
Southwest Airls Co. | 26 | Q3 2019 | 1.3% |
3M Company | 26 | Q3 2019 | 1.2% |
Aflac Incorporated | 26 | Q3 2019 | 1.1% |
View KOPP INVESTMENT ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SUPERCONDUCTOR TECHNOLOGIES INC | August 19, 2016 | 528,963 | 16.6% |
EMCORE CORP | April 01, 2016 | 1,248,970 | 4.8% |
VITESSE SEMICONDUCTOR CORP | May 05, 2015 | ? | ? |
TRANSGENOMIC INC | May 23, 2014 | 83,502 | 1.1% |
RTI SURGICAL, INC. | January 03, 2014 | 1,984,618 | 3.5% |
SYNERGETICS USA INC | January 03, 2014 | 877,253 | 3.5% |
MINDSPEED TECHNOLOGIES, INC | December 13, 2013 | 2,068,416 | 4.8% |
TRANSGENOMIC INC | November 01, 2013 | 13,744,086 | 15.6% |
OCLARO, INC. | September 20, 2013 | 8,592,517 | 9.3% |
SUPERCONDUCTOR TECHNOLOGIES INC | December 21, 2012 | 8,776,335 | 17.4% |
View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2019-11-14 |
13F-HR | 2019-08-14 |
13F-HR | 2019-05-15 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-14 |
13F-HR/A | 2018-08-15 |
13F-HR | 2018-08-14 |
13F-HR | 2018-05-14 |
13F-HR | 2018-02-14 |
13F-HR | 2017-11-14 |
View KOPP INVESTMENT ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.